<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Many statements about the treatment were misleading, said Michael J. DiStefano, PhD, assistant professor of clinical pharmacy at the University of Colorado Anschutz Medical Campus, Aurora and a study co-author.  “We found one case of a straight-up, false statement, saying that ketamine is FDA-approved to treat depression,” DiStefano said. He hopes to expand the research nationally.